Date: 2014-05-13
Type of information: Commercialisation agreement
Compound: ConfirmMDx for Prostate Cancer
Company: MDxHealth (Belgium) American Pathology Partners (USA - CO)
Therapeutic area: Diagnostic - Cancer - Oncology
Type agreement: commercialisation
Action mechanism:
Disease: prostate cancer
Details: * On May 13, 2014, MDxHealth, a molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, announced that it has entered into a co-marketing agreement with American Pathology Partners to promote its ConfirmMDx® for Prostate Cancer test. American Pathology Partners is creating a nationwide network of leading anatomic pathology laboratories, with UniPath in Denver, Colorado, Palm Beach Pathology in West Palm Beach, Florida and Eastern Carolina Pathology in Wilson, North Carolina. The partnership expands MDxHealth\'s customer base to some of the nation\'s leading pathologists who serve urologists in key geographic markets within the United States.
Financial terms:
Latest news:
